IONIS PHARMACEUT reported $267.81M in Current Liabilities for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Agios Pharmaceuticals AGIO:US $ 48.4M 2.6M
Alnylam Pharmaceuticals ALNY:US $ 657.68M 51.72M
Arrowhead Research ARWR:US $ 128.21M 10.64M
Astellas Pharma 4503:JP Y 740538M 53127M
Biomarin Pharmaceutical BMRN:US $ 464.73M 25.69M
Bluebird Bio BLUE:US $ 148.86M 5.97M
Esperion Therapeutics ESPR:US $ 82.28M 3.19M
Exelixis EXEL:US $ 304.52M 15.44M
Halozyme Therapeutics HALO:US $ 199.51M 87.82M
Intercept Pharmaceuticals ICPT:US $ 151.43M 0.39M
Mirati Therapeutics MRTX:US $ 119.15M 4.42M
Moderna Inc MRNA:US 6.81B 2.43B
Nektar Therapeutics NKTR:US $ 104.98M 0.3M
Neurocrine Biosciences NBIX:US $ 285.7M 32.2M
Novartis NOVN:VX SF 27646M 2161M
Omeros OMER:US $ 38.5M 3.44M
Ptc Therapeutics PTCT:US $ 567.37M 90.6M
Regeneron Pharmaceuticals REGN:US $ 3033.9M 26.3M
Sarepta Therapeutics SRPT:US $ 545.57M 90.6M
Ultragenyx Pharmaceutical RARE:US $ 220.64M 53.4M
Vertex Pharmaceuticals VRTX:US $ 2556.2M 376M